Personalized Cannabis based on your DNA

Genetics may influence experience with cannabis and CBD. With increased access to legal cannabis and the research community expanding their focus on the medicinal uses of cannabinoids, more and more consumers are seeking cannabis for health and wellness. However, cannabinoids and terpenes are extremely complex and research tells us that users can have vastly different physiological responses to individual strains/chemovars or products. This makes it almost impossible to find a perfectly aligned product through trial and error. The truth is, cannabis is personal, and uncovering true endocompatibility for each individual user can be scientifically validated. Combining genomics with biomarkers and measurable outcomes allows us to develop better predictive inferences. There are statistics of adverse events with delta9 THC consumption and drug-to-drug interaction resulting in vomiting, abdominal pain and psychotomimetic effects.

Personalized precision therapeutics can be used to support in mitigation of these adverse events by looking at Single Nucleotide Polymorphism (SNPs) along with Pharmacogenomics (PGx) for drug to drug interaction and Pharmacokinetics for dosing based on metabolic function.

Learning Objectives:

1. Discuss how Genetics may influence experience with cannabis and CBD.

2. Explain the scientifically based, genetically focused resource that consistently and reliably matches individuals with the most compatible cannabinoid products.

3. Discuss how a patented technology like EndoDNA uses phyto-canabinoids and therapeutics to align with your DNA and Biometrics for precise dosing and efficacy.